Research programme: azithromycin analogues - EpiEndo Pharmaceuticals
Alternative Names: Azithromycin analogues - EpiEndo Pharmaceuticals; BarriolidesLatest Information Update: 05 Mar 2021
At a glance
- Originator EpiEndo Pharmaceuticals
- Class Anti-inflammatories; Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Chronic obstructive pulmonary disease; Respiratory tract disorders